ArticleOncotarget2016

Reactivation of ERK and Akt confers resistance of mutant BRAF colon cancer cells to the HSP90 inhibitor AUY922.

Chun Yan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.